Journal
Oncotarget
Publication Date
2016
Volume
7
Issue
23
Inclusive Pages
33529-41
Document Type
Open Access Publication
Rights and Permissions
Ohman, K. A., Hashim, Y. M., Vangveravong, S., Nywening, T. M., Cullinan, D. R., Goedegebuure, S. P., . . . Hawkins, W. G. (2016). Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-erastin into a potent pancreatic cancer therapeutic. Oncotarget, 7(23), 33529-33541. 10.18632/oncotarget.9551. Copyright: © Ohman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Ohman, Kerri A.; Hashim, Yassar M.; Vangveravong, Suwanna; Nywening, Timothy M.; Cullinan, Darren R.; Goedegebuure, S. Peter; Liu, Jingxia; Van Tine, Brian A.; Tiriac, Herve; Tuveson, David A.; DeNardo, David G.; Spitzer, Dirk; Mach, Robert H.; and Hawkins, William G., "Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic." Oncotarget. 7, 23. 33529-41. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/6499
